Transfusion · 2026
Multi-center development and validation of a standardized protocol for biotinylated red blood cell analysis.
СтатьяВалидационное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Marschner Susanne, Lee Deborah, Rugg Neeta, Brown Bethany, Nestheide Shawnagay, Wellington Michael, Kanias Tamir, Tatari-Calderone Zohreh, Bhujbal Richa, Finlon Jeff, Rahman Maria, Cancelas Jose A, HOXVITARC group
Аннотация
BACKGROUND: Twenty-four-hour post-transfusion recovery (PTR24) is a key measure of red blood cell (RBC) quality. Traditionally assessed using radioactive chromium-51 (51Cr), supply and facility limitations have prompted the need for alternatives. Biotinylation of RBCs (BioRBCs) offers a non-radioactive method capable of distinguishing multiple RBC populations by flow cytometry. Researchers at three major blood centers developed a standardized BioRBC labeling protocol for pharmacokinetic studies.
STUDY DESIGN AND METHODS: The multicenter development of the standardized protocol followed a two-phase design. First, inter- and intra-site flow cytometry variability was assessed using RBCs biotinylated at 6 and 18 μg/mL. Samples were stained with streptavidin-phycoerythrin (SA-PE), diluted, and analyzed in triplicates using shared flow cytometry templates. Second, inter-site variability of biotinylation was tested using paired RBC units split and processed simultaneously at each site. Separation index (SI) was calculated as: SI = (median BioRBC - median unlabeled)/(84th percentile unlabeled - median unlabeled)/0.995.
RESULTS: Staining and analysis of BioRBCs demonstrated minimal inter- and intra-site variability when using identical protocols. Coefficients of variation for median fluorescence intensity were <7.9% within sites and <5.1% across sites. Biotinylation of paired RBC with 6 and 18 μg/mL of biotin resulted in comparable separation indices, suggesting reliable and reproducible biotinylation ratios.
DISCUSSION: The standardized BioRBC protocol produces reliable, reproducible labeling with minimal inter-site variability. In vivo performance will be assessed in upcoming PTR24 studies comparing BioRBCs with dual radiolabeling using 51Cr and technetium-99m (99mTc).
STUDY DESIGN AND METHODS: The multicenter development of the standardized protocol followed a two-phase design. First, inter- and intra-site flow cytometry variability was assessed using RBCs biotinylated at 6 and 18 μg/mL. Samples were stained with streptavidin-phycoerythrin (SA-PE), diluted, and analyzed in triplicates using shared flow cytometry templates. Second, inter-site variability of biotinylation was tested using paired RBC units split and processed simultaneously at each site. Separation index (SI) was calculated as: SI = (median BioRBC - median unlabeled)/(84th percentile unlabeled - median unlabeled)/0.995.
RESULTS: Staining and analysis of BioRBCs demonstrated minimal inter- and intra-site variability when using identical protocols. Coefficients of variation for median fluorescence intensity were <7.9% within sites and <5.1% across sites. Biotinylation of paired RBC with 6 and 18 μg/mL of biotin resulted in comparable separation indices, suggesting reliable and reproducible biotinylation ratios.
DISCUSSION: The standardized BioRBC protocol produces reliable, reproducible labeling with minimal inter-site variability. In vivo performance will be assessed in upcoming PTR24 studies comparing BioRBCs with dual radiolabeling using 51Cr and technetium-99m (99mTc).